The U.S. Department of Health and Human Services (HHS) in Washington, D.C., which funds much of the nation’s biomedical research, has launched a “comprehensive review” of human fetal tissue research, to ensure that it’s complying with laws and regulations

Quick Read

In the United States, pharmaceutical companies have built a system which supports high costs for HIV drugs. But that may be starting to change

Quick Read

Scientists in the US may be out in front developing the next generation of CRISPR-based genetic tools, but it’s China that’s pushing those techniques toward human therapies the fastest

Quick Read

Our Peter Young traveled to Cuba. He reflects on the resilience he witnessed on his trip and parallels with the US healthcare system

Read More

The complexity of the system comes with costs that aren’t obvious but that we all pay

Quick Read

Dying cannot be understood properly, or responded to well, without recourse to the connections between the dying experience and the larger social structures that make up a social and civic community

Quick Read

Women have more options, for one. But a new poll also shows that financial insecurity is altering a generation’s choices

Quick Read

China is making a bid to use its Ebola vaccine in the Democratic Republic of the Congo. It’s a move that could further complicate efforts to test a crowded field of vaccines and therapies in the context of a waning outbreak

Quick Read